News & Updates
Filter by Specialty:

SOF/VEL combo improves well-being of children with CHC
27 Apr 2025
byStephen Padilla
In children with chronic hepatitis C (CHC), effective treatment with sofosbuvir/velpatasvir (SOF/VEL) results in improvements in certain areas of their well-being at 1 year. This suggests some patient-reported outcomes (PRO) benefits of direct-acting antiviral (DAA) therapy. However, the parents’ proxy reports show a decrease in the patients’ school functioning.
SOF/VEL combo improves well-being of children with CHC
27 Apr 2025
Progestin-only contraceptives may pose NAFLD risk among women with GDM history
25 Apr 2025
byJairia Dela Cruz
The use of progestin-only contraceptives may put women with a history of gestational diabetes mellitus (GDM) at risk of nonalcoholic fatty liver disease (NAFLD), as shown in a small prospective study.